Back to search

Article

Galectin approach to lower covid transmission - Drug Development for clinical use

2022-11-10

Abstract excerpt

<h4>Background</h4> SARS-CoV-2 vaccines play an important role in reducing disease severity, hospitalization, and death, although they failed to prevent the transmission of SARS-CoV-2 variants. Therefore, an effective inhibitor of galectin-3 (Gal-3) could be used to treat and prevent transmission of COVID-19. ProLectin-M (PL-M), a Gal-3 antagonist, has been shown to interact with Gal-3 and thus prevent cellular en...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f60eba18-cb4f-5aa9-9a1f-28f4bb79471c
DOI
10.1101/2022.11.09.22282151
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Galectin approach to lower covid transmission - Drug Development for clinical useDOI 10.1101/2022.11.09.22282151
Select a neighboring publication to make it the new centre.